In the present study, we investigated the involvement of OSM in experimental and human NAFLD/NASH and we performed experiments in order to elucidate whether this cytokine may act directly on LX2 cells and primary culture of human HSC/MFs by regulating selected pro-fibrogenic phenotypic responses. This evidence concerns the gene OSM and metabolic dysfunction-associated steatotic liver disease.